How do GLP-1 brands recover leads who start enrollment but don't finish?

A lead clicks through from an ad and starts your eligibility quiz. They answer the first questions, reach the part about cost, insurance, or medication history, and close the page. The signup stays unfinished. Your acquisition spend is in the funnel, but the lead is gone before enrollment.

The way to bring that lead back is to ask what stopped them while the question is still fresh. Hello Patient builds conversational AI agents for consumer health brands. The agent reaches out when someone leaves an eligibility quiz, intake, or cart unfinished, asks what got in the way, and answers in the same thread. That is how it recovers abandoned GLP-1 eligibility quizzes.

A Series B GLP-1 brand saw a 140% lift over the static re-engagement program it replaced.

This leak is expensive because the lead was moving. They found the brand and started enrollment. Then the process reached something they were not ready to answer on their own.

A scheduled sequence can't hear that question. It can send the next message, but it still has to guess why the lead stopped.

Why warm GLP-1 leads stop partway through

Most stalled signups stop over a question the enrollment flow did not settle. The lead may be unsure about price, whether insurance helps, whether the medication is safe alongside another drug they take, or how compounded and branded medication differ.

Those are different objections, and they do not respond to the same message. A lead worried about a medication interaction does not need a discount. A lead who does not understand the monthly cost does not need another reminder to finish the quiz.

Lifecycle sequences can remind someone that the signup is waiting. But the message is written before the lead replies, so it cannot change course when the real blocker appears.

One message talks about convenience. The next offers an incentive. A third says the signup only takes a few minutes. The lead's question stays unanswered, and each new touch feels less relevant.

What brings a stalled signup back

A stalled signup comes back when the lead can ask the question that made them stop and get a useful answer without starting over. The agent opens that exchange at the point of the drop and keeps it in one thread.

The first message can be simple: you started signing up but did not finish. Was there something you wanted to ask?

If the lead asks about cost, the agent explains the approved pricing details and what happens next. If they ask about insurance, it gives the brand's approved answer and directs them to the right next step. If they are unsure about compounded versus branded medication, it explains the difference using language the brand has approved.

When the question needs medical judgment, the agent sends the conversation to the care team with the context attached.

How the agent fits into the stack you run

The agent works alongside the CRM, lifecycle platform, and enrollment tools in place. It adds a two-way conversation where the current stack usually sends a one-way follow-up.

The brand can keep its existing triggers and audience logic. When a lead leaves partway through, that event starts the conversation. The agent asks what happened, handles approved operational questions, and sends the lead back to the right step when they are ready.

Marketing platforms like Braze and Klaviyo set limits on sending sensitive medical information. Their BAAs and use policies draw the line in different places, so it is worth checking before routing a health question through them. An agent built for healthcare and operating under a BAA is an appropriate place for these conversations. We cover the broader setup in our guide to HIPAA-compliant lifecycle automation for GLP-1 brands.

Hello Patient is HIPAA-compliant, SOC 2 Type 2 certified, and signs a BAA with every client.

One GLP-1 brand's recovery numbers

One Series B GLP-1 brand used the agent to follow up with leads who started enrollment and stopped before finishing. The agent went live in under three weeks, with no engineering work on the brand's side.

Across 92,290 leads over 16 months, the agent recovered 4,739 stalled signups. That was a 5.13% conversion rate and a 140% lift over the static re-engagement program it replaced.

A recovery rate is not the same as incremental lift. Some leads may have returned without the agent. The clean way to measure the added value is to hold out a control group and compare what happens.

You should demand that proof from every vendor, us included. Our guide to measuring GLP-1 recovery incrementality with a holdout explains how to set up the test.

Clinical questions stay with your care team

The agent handles enrollment questions that can be answered from approved brand information. Medical judgment stays with the care team.

A lead may ask whether the medication is safe with another drug, whether a symptom is normal, or whether they should change a dose. The agent routes that conversation to the medical team with the earlier messages attached. It does not try to practice medicine.

The brand decides which topics the agent can answer and which ones go to a person.

The same leak shows up later in the member lifecycle

The unfinished quiz is one version of a larger problem. After signup, members still pause when a question arrives and nobody answers it in the channel they are using.

A member may be waiting for the first shipment and unsure what happens next. Another may have a dosing question that needs the care team. Someone else may miss a refill step or stop responding before renewal.

The agent can answer approved operational questions, route medical questions, and follow up when a member goes quiet. The same principle holds throughout the lifecycle: ask what stopped the person, then deal with that reason in the same thread.

The handoff from lead to member should not create a new gap.

Where to start measuring the leak

Start with the leads who began your eligibility quiz, intake, or cart and did not finish. Break them out by the step where they stopped, then look at how many received a real reply instead of a scheduled reminder.

That gives you the first view of the leak. A holdout tells you how much of the recovery is truly incremental.

To see how the agent would work against your own funnel, book a call. We can map the drop points, the questions that appear at each one, and the handoffs that need to stay with your care team.

Find out whether Hello Patient fits your brand. Book a call and we'll show you what can change. Read more here!

Make sure to ask for a free demo agent to see how it will look to your members.

Frequently asked questions

How is recovering a stalled GLP-1 signup different from recovering an abandoned cart?

A stalled GLP-1 signup often involves a question about cost, insurance, medication, or what happens next. A standard abandoned-cart message usually reminds the person to return, but it does not learn why they left. Hello Patient's agent starts a two-way conversation instead. It asks what stopped the lead, answers approved operational questions in the same thread, and sends medical questions to the care team with the context attached. The lead can then return to the right point in the signup flow without starting the conversation over or receiving a generic discount that does not address the reason they stopped.

What does a conversational AI agent say to a GLP-1 lead who stalled on cost or insurance?

The agent starts by asking what prevented the lead from finishing, rather than assuming the reason. If the lead asks about cost, Hello Patient's agent can explain the pricing information the brand has approved and clarify what happens next. If the question is about insurance, it gives the approved coverage information or directs the lead to the appropriate next step. The conversation stays in the same text thread, so the lead can ask a follow-up question instead of searching through the website or restarting enrollment. Once the question is settled, the agent can guide the lead back to the point where the signup stopped.

Is texting GLP-1 leads about their health HIPAA-compliant?

It can be, provided the conversation is handled in an appropriate environment and the right agreements are in place. Hello Patient is HIPAA-compliant, SOC 2 Type 2 certified, and signs a BAA with every client. The brand also defines what the agent may answer using approved information and what must go to the care team. Questions about price, insurance, timing, and the enrollment process may be handled by the agent. Questions that require medical judgment are routed to the care team with the earlier messages attached. Brands should also check the BAA and use-policy limits of any marketing platform involved in the conversation.

How fast can a GLP-1 brand put a signup-recovery agent live?

One Series B GLP-1 brand put the agent live in under three weeks, with no engineering work required on the brand's side. Hello Patient configured the agent around the places where leads stopped, the answers the brand had approved, and the questions that needed to be routed to the care team. The agent then worked alongside the enrollment, CRM, and lifecycle tools the brand used rather than replacing them. The exact setup depends on the funnel and the rules the brand wants the agent to follow, but the work centers on defining the trigger, approved responses, return path, and medical handoffs.

How do I know the GLP-1 signups an AI agent recovers are incremental?

Use a control group. Let Hello Patient's agent contact one group of stalled leads while a comparable group continues through the existing program without the agent. The difference between the two groups is the best measure of incremental lift. A recovery rate alone cannot answer that question because some leads may have returned without any additional outreach. That is why recovered signups and incremental signups should not be treated as the same number. Hello Patient recommends that brands build the holdout into the program from the start and require every vendor, including Hello Patient, to show the result against that control.

Do GLP-1 leads actually reply to a text from an AI agent?

Yes, leads reply to the agent, though the response and recovery rates will vary by brand, audience, timing, and message. The point of the first text is to open a conversation, not pressure every lead back into enrollment. A lead can explain what stopped them, ask a question, or say they are no longer interested. They can also text STOP, and the conversation ends there with no further scheduled follow-ups. Hello Patient recommends measuring replies separately from recovered signups so the brand can see how many leads engage, what questions are causing the drop, and how many ultimately return to finish the signup.

What recovery rate can a GLP-1 brand expect from stalled eligibility quizzes?

There is no single recovery rate that every GLP-1 brand should expect. Funnel design, lead source, timing, pricing, and the questions causing people to stop will affect the result. In one Series B GLP-1 program, Hello Patient's agent converted 5.13% of 92,290 leads over 16 months and recovered 4,739 stalled signups. That represented a 140% lift over the static re-engagement program it replaced. Those numbers are useful proof that the approach can work, but they should not be treated as a universal benchmark. A control group is still required to separate recovered signups from true incremental lift.

Have a stalled-signup leak you want to measure? Book a call.